Good Afternoon. 98 years ago today — a bakery in Chillicothe, Missouri rolled out the first commercial loaves of sliced bread.

Every "best thing since sliced bread" cliché traces back to that morning. In 2026 that title has belonged to AI accelerators — but today the market decided maybe the loaf's been a little over-baked.

Samsung posted a record 89.4 trillion won Q2 profit and its stock fell 7%. The Kospi crashed 4.9%. The VanEck Semi ETF (SMH) dropped 4.5% on a session where the S&P only slipped ~0.51%.

—Rosie, Wyatt, Evan & Conor

🔥 What’s Hot: 🔥

🥶 What’s Not: 🥶

🔢 Big number: $80 billion — the amount of market cap Samsung Electronics investors erased after the world's largest memory-chip maker announced a 19-fold jump in Q2 operating profit. Investors sold anyway because expectations were, apparently, a 20-fold jump.

1. Chips take another leg down

The news: Yesterday's Nasdaq bounce turned out to be a one-day affair. On Tuesday the VanEck Semiconductor ETF (SMH) dropped 4.49%, the Nasdaq 100 shed 1.92%, and the VIX climbed back above 20. AMD was the day's worst mega-cap performer at -6.53%, Tesla fell 4.02%, and Broadcom slipped 1.46% even as the company unveiled a new custom-silicon deal with Apple through 2031. The trigger was 6,500 miles away: Korea's Kospi got hammered 4.9% overnight after Samsung and SK Hynix — the two names that supply HBM memory for Nvidia systems — sold off despite Samsung posting a record quarter.

Big picture: This is a valuation reset, not a demand collapse. Samsung's numbers were great — a 19-fold profit jump beats every peer on earth right now. But when a stock has run ~100% in 12 months and every hedge fund is long, "great" isn't good enough to hold the line. The Philadelphia Semi Index is now down about 14% from June's peak, which historically is where contrarian long-only money starts sniffing. The Nvidia earnings report on August 27 is the next real catalyst — if guidance holds, this whole 3-week de-grossing episode gets erased in a hurry. If it disappoints, we're not done.

Source: Reuters / CNBC / NYT

2. SpaceX officially crashes the Nasdaq 100

The news: SpaceX became a full member of the Nasdaq 100 at Tuesday's close, just 25 days after its June 12 IPO — one of the fastest index inclusions in the modern era thanks to Nasdaq's revised rules for mega-cap new listings. J.P. Morgan estimates the mechanical passive demand at $4.3 billion, while WSJ put the broader ETF universe tracking the index at roughly $800 billion. Analysts kicked off coverage with a broadly bullish consensus ($300 price target from one desk vs. Monday's $160.42 close, an 87% implied gain). Shares were down about 1.8% in premarket amid the broader tech selloff and finished lower on the day.

What's next: The passive-flow surge is a one-time event; the real story is what happens after. With less than 5% of shares actually floating, SpaceX joins the index at roughly a <1% weight despite a $2.1 trillion market cap — bigger than JPMorgan, smaller than Nvidia. Every quarterly report and every Musk tweet now moves the entire QQQ. Watch for two things over the next 90 days: whether analysts start covering Starlink ARPU and Starshield defense contracts as separate business lines, and whether the free-float creeps up through secondary offerings — either would pull SpaceX's index weight higher.

Source: Reuters / CNN / Globe & Mail

3. Vertex buys Crinetics for $10 billion

The news: Vertex Pharmaceuticals is paying $85 per share in cash — roughly $10 billion equity value, $8.8 billion net of Crinetics' cash — for Crinetics Pharmaceuticals, a 102% premium to Friday's close. Crinetics doubled in Monday's extended session and gapped up nearly 99% in Tuesday premarket. The prize: Palsonify, the first once-daily oral pill for acromegaly (approved by the FDA in September 2025), plus atumelnant, a Phase-3 candidate for congenital adrenal hyperplasia. Vertex expects combined peak sales north of $5 billion and calls it accretive to non-GAAP operating income by 2029.

Bottom line: Big pharma is on a spending spree. Cystic-fibrosis specialist Vertex has been shopping for a fifth revenue pillar for years, and endocrinology fits — small addressable populations, sticky adult chronic-disease scripts, less commercial competition than oncology. The $4.5 billion bridge financing from BofA and Morgan Stanley means this closes on schedule (Q3 2026 target), and the modest $350.5M break fee leaves the door cracked for an interloper like Novartis, Lilly, or Novo. Biotech M&A is now at 18 deals YTD worth more than $1B each — the sector's investable universe is shrinking by the week.

Source: WSJ / U.S. News

4. Microsoft cuts 4,800 more jobs

The news: Microsoft confirmed it's letting go of 4,800 employees, roughly 2.1% of headcount, in the second major reduction of 2026. The Xbox and gaming division takes the biggest hit at ~1,600 in the first wave and eventually 3,200 total, hollowing out several studios acquired in the Activision deal (Compulsion, Double Fine, Undead Labs). This is on top of ~9,000 cuts in May, bringing 2026's total to more than 13,000 — even as CEO Satya Nadella promises $190 billion in AI infrastructure capex over the next five years.

What's next: Microsoft's message is straightforward: gaming and legacy engineering are getting rebased so budget can be redirected into Azure AI, Copilot, and OpenAI infrastructure. Wall Street likes it — MSFT is one of the few tech names green on a broadly red day. But watch the Xbox brand equity math: the console business has been eaten alive by mobile and PC, and every wave of studio cuts weakens Game Pass content pipeline. If Nadella hollows out gaming too far, Sony walks away with the console generation and Microsoft is left with a subscription service that has nothing to subscribe to.

Source: USA Today / Axios / Newsweek

5. O'Reilly makes a $10B pass at Genuine Parts

The news: Aftermarket auto-parts giant O'Reilly Automotive offered more than $10 billion in cash for the auto-parts business of Genuine Parts — the NAPA-branded distribution arm. It's an unsolicited approach and Genuine Parts hasn't formally responded, but Wall Street's already handicapping the antitrust angle: combining O'Reilly's 6,300 stores with NAPA's 6,000 U.S. locations creates a dominant DIY and professional-installer network. ORLY shares initially tumbled 6.7% on the news (deal risk, dilution) before recovering as investors ran the synergy math. GPC's overall stock actually finished up — investors see a bidder emerging.

Bottom line: This is a classic industry-consolidation moment in a fragmented category. The auto-aftermarket has held up well through EV adoption because Americans keep vehicles longer (average age now 12.7 years), and repair demand is baseline recession-proof. If ORLY-NAPA clears antitrust, expect AutoZone ($AZO) to feel the squeeze and a fresh look at Advance Auto Parts as a takeout target. For consumers, near-term this is background noise; long term, less competition in your local strip mall.

Source: Yahoo Finance company news

6. Kospi circuit-breaker: -4.9%

The news: South Korea's Kospi halted trading for 20 minutes Tuesday after tumbling more than 8% intraday, ultimately closing down 4.9%. Samsung Electronics finished -6.9% after posting a record 89.4 trillion won ($58.4B) operating profit — a 19-fold year-over-year jump — that still fell short of stretched expectations. SK Hynix dropped 6%, SK Square cratered 12.78%, and the broader Samsung group lost more than $80 billion in market cap on the session. Japan's Nikkei fell 2.12%, and the region's tech sector gave back about half of the past week's gains.

Big picture: The Kospi is up almost 100% over 12 months, and Goldman Sachs estimates 90% of that move came from Samsung and Hynix alone. When two stocks carry an entire benchmark, they carry the profit-taking too — that's what "sell the news" looks like in a concentrated index. If SK Hynix's U.S. secondary listing (opening Friday) prices at the top of the range, the story still has legs. If it prices at the bottom, we've got a longer digestion phase ahead.

Source: Chosun / Reuters / CNBC

7. Broadcom + Apple lock in through 2031

The news: Broadcom and Apple extended their existing custom-silicon partnership through 2031, per an SEC filing Tuesday. AVGO shares initially rallied 3.7% on the news before giving it all back and closing -1.46% on the broader semi rout. The deal covers a range of components including modems, Wi-Fi/Bluetooth radios, and increasingly custom AI accelerators built on TSMC's latest nodes. Apple has been very publicly working to reduce reliance on Broadcom (bringing modem design in-house with the C1 chip), so a 5-year extension is a genuine strategic surprise.

What's next: This locks in Broadcom's biggest customer through the end of the decade, at a moment when the market's questioning whether AI-chip demand is peaking or pausing. It also tells you Apple's in-house silicon program isn't ready to fully replace Broadcom's wireless expertise yet — the C1 modem shipped in a single low-volume iPhone SKU last year, and volume ramp appears to be slower than Apple's roadmap suggested. For Broadcom at a $2 trillion market cap, this contract alone anchors roughly 20% of expected wireless-segment revenue through 2028.

Source: Yahoo Finance company news

8. Walmart hits the price-cut button

The news: Walmart said Tuesday it's cutting prices on thousands of grocery and general-merchandise items — including ground beef, Coca-Cola, ice cream, and toys — for the summer, funded in part by tariff refunds it received earlier this year. Company internal data pegs the average grocery basket savings at ~7% vs. May. President Trump publicly took credit ("Walmart's doing this because of me") in a Truth Social post; company execs politely declined to comment on political attribution and said the cuts reflect ongoing supply-chain productivity gains.

Bottom line: Walmart's price cuts do two things — they help low-income households actually stretch grocery budgets in a still-3.2% CPI environment, and they put competitive pressure on Kroger, Target, and Aldi to follow. Walmart's already the biggest U.S. grocer with ~26% share; if the cuts stick through Q3, expect share to nudge toward 28% and the smaller regional chains to bleed. If food inflation ticks another leg down as a result, that's a modest tailwind for the Fed's late-2026 rate-cut math. For shoppers, this is real — average savings of 11 cents per pound on ground beef adds up over a summer of cookouts.

Source: NY Post / CNN / CBS News

Q: What's a robot's favorite snack?

A: Computer chips.

Beta measures how much a security's price moves relative to the broader market. A stock with beta 1.0 moves in lockstep with the index; beta 2.0 swings twice as hard both directions; beta 0.5 is half as volatile. It comes from William Sharpe's Capital Asset Pricing Model and it's the numerator in almost every CFP® risk conversation you'll ever have.

Why now? Today was a beta-in-action case study. The S&P 500 fell 0.54%. If semis had beta 1.0, SMH would have fallen the same. Instead it dropped 4.49% — roughly 8× the market move. That's what happens when high-beta names get caught in a de-grossing episode: the same trait that made them outperform on the way up (chips were up 60% YTD before June) makes them underperform brutally on the way down. The portfolio lesson isn't "avoid high beta" — high beta is where the best long-term compounding often lives. It's know what you own, size positions accordingly, and don't confuse a beta-driven drawdown with a broken thesis. A $10,000 position in a beta-2.0 stock behaves like a $20,000 S&P position on volatile days. Plan for that math before you buy, not after you've been shaken out.

Tech Moves Fast. TLDR Helps You Keep Up.

From AI breakthroughs to startup trends and market-moving innovation, technology is reshaping how businesses grow and investors think. TLDR gives 1.6 million readers a quick daily breakdown of the most interesting stories in tech, startups, and programming. It’s a simple way to stay ahead of the trends driving the future economy. Sign-up here.